Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Howard R, Lee"'
Autor:
Howard R. Lee, Parth Shah, Farouk Mookadam, Thai H. Ho, Sherif Moustafa, Bhargava K. Nelluri, Susan Wilansky, Katie Murphy
Publikováno v:
Journal of Clinical Ultrasound. 44:221-230
Purpose We aimed to explore the hypothesis that early subclinical cardiac chamber dysfunction secondary to tyrosine kinase inhibitors (TKIs) in patients with metastatic renal cell carcinoma could be signaled by abnormal cardiac mechanics demonstrated
Autor:
Katie Murphy, Bhargava K. Nelluri, Parth Shah, Susan Meyer, Donald W. Northfelt, Sherif Moustafa, Howard R. Lee, Tasneem Z. Naqvi, Susan Wilansky, Farouk Mookadam
Publikováno v:
Echocardiography. 33:406-415
Background Trastuzumab has substantially improved overall survival and reduced the risk of disease recurrence in patients with human epidermal growth factor receptor type II (HER-II)–positive breast cancer. However, this benefit may be at the incre
Autor:
Howard R. Lee, Suryakanth R. Gurudu, Sylvia A. Mamby, Rafael Miranda, Jonathan A. Leighton, Sean W. Glenn, Shabana F. Pasha, Margaret F. Johnson, T. S. Raghu, Harry G. Teaford, Lester E. Mertz
Publikováno v:
Journal of Healthcare Management. 60:363-376
The emerging changes in healthcare impose significant burdens on integrated outpatient specialty services with respect to setting patient expectations, handling outside medical records; and coordinating specialty appointments scheduling. Moreover, be
Autor:
Fayaz A. Hakim, Anil Pandit, Aashrayata Aryal Pandit, Leena Jalota, Howard R. Lee, Sudheer Kantharajpur, Madan Raj Aryal
Publikováno v:
Heart, Lung and Circulation. 23:303-308
Objective To review efficacy of percutaneous closure of patent foramen ovale compared with medical therapy in prevention of recurrent strokes in patients with cryptogenic stroke. Methods and Results Electronic databases; PUBMED, EMBASE, Cochrane regi
Autor:
Roger L. Click, Jhansi L. Ganji, Hari P. Chaliki, Hartzell V. Schaff, D. Craig Miller, Howard R. Lee, Mohammad Q. Najib
Publikováno v:
Journal of Cardiac Surgery. 28:139-143
Osteogenesis imperfecta (OI) or "brittle bone disease" is a rare connective tissue hereditary disorder. The most common clinical presentation of OI is bone fractures. OI also involves extraskeletal structures; however, cardiovascular manifestations a
Autor:
Suresh Challa, Hari P. Chaliki, Satya S. Vittala, Howard R. Lee, Mohammad Q. Najib, Karyne L. Vinales
Publikováno v:
Echocardiography. 29:140-146
Background and Aims: Atrial fibrillation (AF) may be a risk factor for severe functional tricuspid valve regurgitation (FTR). We aimed to determine the predictors of severe FTR in patients with AF. Methods and Results: From our echocardiographic labo
Autor:
Rafael, Miranda, Sean W, Glenn, Jonathan A, Leighton, Shabana E, Pasha, Suryakanth R, Gurudu, Harry G, Teaford, Lester E, Mertz, Howard R, Lee, Sylvia A, Mamby, Margaret F, Johnson, T S, Raghu
Publikováno v:
Journal of healthcare management / American College of Healthcare Executives. 60(5)
The emerging changes in healthcare impose significant burdens on integrated outpatient specialty services with respect to setting patient expectations, handling outside medical records; and coordinating specialty appointments scheduling. Moreover, be
Publikováno v:
Frontiers in Oncology, Vol 4 (2014)
Frontiers in Oncology
Frontiers in Oncology
Globally, cancer is diagnosed in approximately 13 million people each year. Approximately 1.6 million cancer patients are seen by cancer clinics across the United States (US) at this time. Over the next two decades, cancer incidence is estimated to i
Autor:
Mohammad Q, Najib, Satya S, Vittala, Suresh, Challa, Amol, Raizada, Fernando J, Tondato, Howard R, Lee, Hari P, Chaliki
Publikováno v:
Texas Heart Institute journal. 40(5)
Patients with permanent pacemaker or automatic implantable cardioverter-defibrillator (AICD) leads have an increased prevalence of tricuspid regurgitation. However, the roles of cardiac rhythm and lead-placement duration in the development of severe
Autor:
Madan Raj Aryal, Imad M. Tleyjeh, Farouk Mookadam, Fayaz A. Hakim, Anil Pandit, Howard R. Lee, Leena Jalota, Aashrayata Aryal Pandit
Publikováno v:
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 9(11)
Aims: Cangrelor is a new antiplatelet agent that has been used in percutaneous coronary intervention (PCI) with mixed results. We aim to review the evidence on the efficacy of cangrelor in comparison to clopidogrel in reducing ischaemic endpoints at